Cargando…
Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada
BACKGROUND: Amid a Canadian opioid crisis, many have turned to natural health products, such as kratom (Mitragyna speciosa), to manage their opioid withdrawal. Kratom has also been reported to relieve anxiety, improve stamina, and heighten physical performance. Given that kratom is not authorized fo...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977165/ https://www.ncbi.nlm.nih.gov/pubmed/33741009 http://dx.doi.org/10.1186/s13011-021-00361-2 |
_version_ | 1783667085345292288 |
---|---|
author | Ng, Jeremy Y. Ans, Muhammad Marwaha, Amn |
author_facet | Ng, Jeremy Y. Ans, Muhammad Marwaha, Amn |
author_sort | Ng, Jeremy Y. |
collection | PubMed |
description | BACKGROUND: Amid a Canadian opioid crisis, many have turned to natural health products, such as kratom (Mitragyna speciosa), to manage their opioid withdrawal. Kratom has also been reported to relieve anxiety, improve stamina, and heighten physical performance. Given that kratom is not authorized for sale by Health Canada, many have turned to online retailers to purchase kratom due to its easy accessibility online. This study investigated the quality of consumer health information provided on the websites of online vendors selling kratom to consumers in Canada. METHODS: Following searches on Google.ca using search terms designed to simulate the information-seeking behaviour of a typical patient-user online, eligible websites were assessed using the 16-question DISCERN instrument, a tool designed to assess the quality of consumer health information. Searches were conducted on March 27, 2020 and only websites presenting information in English were included. RESULTS: A total of 200 webpages were identified; after screening based on eligibility criteria and combining different webpages that belonged to the same website, 51 websites were found to be eligible. The mean summed DISCERN score across all 51 websites was 36.95 (SD = 2.44) out of 75, which reflects poor quality consumer health information across the subset of websites. The overall quality of websites was poor, as 78% (n = 40) of vendors received a score of 2 or less out of 5. CONCLUSIONS: Individuals who seek information about kratom online are frequently exposed to poor quality consumer health information. Those looking to purchase kratom online are not provided with the critical information necessary to make an informed decision regarding its use, such as the complete details about the risks and side effects or a description of how kratom affects the body. Given the growing interest in kratom, knowledge of the quality of information available can lead to improved dialogue between healthcare providers and patients. |
format | Online Article Text |
id | pubmed-7977165 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79771652021-03-22 Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada Ng, Jeremy Y. Ans, Muhammad Marwaha, Amn Subst Abuse Treat Prev Policy Research BACKGROUND: Amid a Canadian opioid crisis, many have turned to natural health products, such as kratom (Mitragyna speciosa), to manage their opioid withdrawal. Kratom has also been reported to relieve anxiety, improve stamina, and heighten physical performance. Given that kratom is not authorized for sale by Health Canada, many have turned to online retailers to purchase kratom due to its easy accessibility online. This study investigated the quality of consumer health information provided on the websites of online vendors selling kratom to consumers in Canada. METHODS: Following searches on Google.ca using search terms designed to simulate the information-seeking behaviour of a typical patient-user online, eligible websites were assessed using the 16-question DISCERN instrument, a tool designed to assess the quality of consumer health information. Searches were conducted on March 27, 2020 and only websites presenting information in English were included. RESULTS: A total of 200 webpages were identified; after screening based on eligibility criteria and combining different webpages that belonged to the same website, 51 websites were found to be eligible. The mean summed DISCERN score across all 51 websites was 36.95 (SD = 2.44) out of 75, which reflects poor quality consumer health information across the subset of websites. The overall quality of websites was poor, as 78% (n = 40) of vendors received a score of 2 or less out of 5. CONCLUSIONS: Individuals who seek information about kratom online are frequently exposed to poor quality consumer health information. Those looking to purchase kratom online are not provided with the critical information necessary to make an informed decision regarding its use, such as the complete details about the risks and side effects or a description of how kratom affects the body. Given the growing interest in kratom, knowledge of the quality of information available can lead to improved dialogue between healthcare providers and patients. BioMed Central 2021-03-19 /pmc/articles/PMC7977165/ /pubmed/33741009 http://dx.doi.org/10.1186/s13011-021-00361-2 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ng, Jeremy Y. Ans, Muhammad Marwaha, Amn Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada |
title | Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada |
title_full | Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada |
title_fullStr | Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada |
title_full_unstemmed | Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada |
title_short | Assessing the quality of information provided on websites selling Kratom (Mitragyna speciosa) to consumers in Canada |
title_sort | assessing the quality of information provided on websites selling kratom (mitragyna speciosa) to consumers in canada |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977165/ https://www.ncbi.nlm.nih.gov/pubmed/33741009 http://dx.doi.org/10.1186/s13011-021-00361-2 |
work_keys_str_mv | AT ngjeremyy assessingthequalityofinformationprovidedonwebsitessellingkratommitragynaspeciosatoconsumersincanada AT ansmuhammad assessingthequalityofinformationprovidedonwebsitessellingkratommitragynaspeciosatoconsumersincanada AT marwahaamn assessingthequalityofinformationprovidedonwebsitessellingkratommitragynaspeciosatoconsumersincanada |